Great Gemcitabine Tactics You Are Not Using

2 mg/dL, serum aspartate aminotransferase http://www.selleckchem.com/products/Gemcitabine-Hydrochloride(Gemzar).html were excluded from this study. Several cycles of leukapheresis were performed after chemotherapy or intravenous administration of cyclophosphamide (single dose of 3.0 g/m2 BSA) to obtain at least 1 million CD34+ cells per kilogram of patient body weight for cryopreservation. If the number of peripheral blood stem cells collected did not reach 1 million per kilogram, auxiliary bone marrow harvest was performed to meet the required number of stem cells. Combination regimen consisting of mitoxantrone, etoposide, cytarabine, and melphalan was used for HDC before autologous transplantation. Mitoxantrone 12 mg/m2 BSA was intravenously infused daily from day-6 to day-4. Etoposide 100 mg/m2 BSA and cytarabine 100 mg/m2 BSA was also administered intravenously every 12 hr from day-6 to day-3. In addition, http://www.selleckchem.com/products/birinapant-tl32711.html melphalan 140 mg/m2 BSA was infused once at day-2. Prevention of tumor lysis syndrome has been done in a usual manner. Electrocardiogram was monitored from day-6 to day-2. Antimicrobial prophylaxis was performed from day-6: antifungal prophylaxis with either oral fluconazole or intravenous micafungin and antibacterial prophylaxis with oral ciprofloxacin. Serotonin antagonist and benzodiazepine were used to prevent chemotherapy-induced emesis. Recombinant granulocyte colony stimulating factor (G-CSF) was administered via an intravenous or subcutaneous route from day +1 until recovery of neutrophil count over 3,000 mm3. The primary objective was to evaluate event-free survival (EFS) of patients. The secondary objectives were to evaluate overall survival (OS) and response rate of patients with measurable lesions and treatment-related adverse events and to elucidate risk factors affecting treatment results. The candidate risk factors were as follows: age, sex, histology, http://www.selleck.cn/products/azd9291.html Ann Arbor stage, number of prior treatments, prior anthracycline dose, response to prior therapy, stem cell source, serum lactate dehydrogenase (LDH; cutoff, 500 IU/L), serum albumin (cutoff, 4.0 g/dL), and hemoglobin (cutoff, 10.0 g/dL). Tumor histology was classified as the World Health Organization classification updated in 2008. Treatment outcomes were evaluated by the revised response criteria updated in 2007 [14]. EFS was calculated from the treatment initiation to any treatment failure including disease progression, toxicity, patient preference, initiation of new treatment without documented progression, or death.